Birdwatch Note
2024-04-03 08:24:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Herr Kuhr verbreitet Fake News. Die zitierte Studie konzentriert sich auf die Wirksamkeit des bivalenten COVID-19-Impfstoffs und erwähnt keine spezifischen negativen Auswirkungen oder Nebenwirkungen der Impfung. Andere Studien bestätigen aber, das die Impfung sicher ist. https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v5 https://www.pei.de/DE/newsroom/dossier/coronavirus/arzneimittelsicherheit.html
Written by 9452793CA0BDF1B068816CDBB3C798F111A02DDEE33B4E1B4BB94176F1DD5310
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1775406832061682098
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1775439219248296389
- noteId - 1775439219248296389
- participantId -
- noteAuthorParticipantId - 9452793CA0BDF1B068816CDBB3C798F111A02DDEE33B4E1B4BB94176F1DD5310 Participant Details
- createdAtMillis - 1712132670595
- tweetId - 1775406832061682098
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Herr Kuhr verbreitet Fake News. Die zitierte Studie konzentriert sich auf die Wirksamkeit des bivalenten COVID-19-Impfstoffs und erwähnt keine spezifischen negativen Auswirkungen oder Nebenwirkungen der Impfung. Andere Studien bestätigen aber, das die Impfung sicher ist. https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v5 https://www.pei.de/DE/newsroom/dossier/coronavirus/arzneimittelsicherheit.html
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-03 08:24:30 UTC (1712132670595) |
2024-04-03 11:22:43 UTC (1712143363971) |
CURRENTLY_RATED_HELPFUL | 2024-04-03 11:22:43 UTC (1712143363971) |
CURRENTLY_RATED_HELPFUL | 2024-04-03 11:22:43 UTC (1712143363971) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-03 05:28:38 -0500 | Rating Details | |
| 2024-04-03 05:18:50 -0500 | Rating Details | |
| 2024-04-03 05:06:47 -0500 | Rating Details | |
| 2024-04-03 05:03:15 -0500 | Rating Details | |
| 2024-04-03 04:54:02 -0500 | Rating Details | |
| 2024-04-03 04:52:09 -0500 | Rating Details | |
| 2024-04-03 04:46:40 -0500 | Rating Details | |
| 2024-04-03 04:32:21 -0500 | Rating Details | |
| 2024-04-03 04:25:02 -0500 | Rating Details | |
| 2024-04-03 04:17:19 -0500 | Rating Details | |
| 2024-04-03 04:15:04 -0500 | Rating Details | |
| 2024-04-03 04:10:44 -0500 | Rating Details | |
| 2024-04-03 04:08:02 -0500 | Rating Details | |
| 2024-04-03 04:07:48 -0500 | Rating Details | |
| 2024-04-03 04:05:23 -0500 | Rating Details | |
| 2024-04-03 03:57:49 -0500 | Rating Details | |
| 2024-04-03 03:57:33 -0500 | Rating Details | |
| 2024-04-03 03:56:50 -0500 | Rating Details | |
| 2024-04-03 03:53:43 -0500 | Rating Details | |
| 2024-04-03 03:40:14 -0500 | Rating Details | |
| 2024-04-03 03:35:14 -0500 | Rating Details | |
| 2024-04-03 03:32:15 -0500 | Rating Details | |
| 2024-04-03 03:30:33 -0500 | Rating Details | |
| 2024-04-03 12:34:35 -0500 | Rating Details | |
| 2024-04-03 12:23:30 -0500 | Rating Details | |
| 2024-04-03 11:39:10 -0500 | Rating Details | |
| 2024-04-03 11:33:23 -0500 | Rating Details | |
| 2024-04-03 10:18:02 -0500 | Rating Details | |
| 2024-04-03 10:05:15 -0500 | Rating Details | |
| 2024-04-03 10:05:02 -0500 | Rating Details | |
| 2024-04-03 09:43:12 -0500 | Rating Details | |
| 2024-04-03 09:41:55 -0500 | Rating Details | |
| 2024-04-03 08:57:09 -0500 | Rating Details | |
| 2024-04-03 08:33:01 -0500 | Rating Details | |
| 2024-04-03 08:28:48 -0500 | Rating Details | |
| 2024-04-03 08:20:11 -0500 | Rating Details | |
| 2024-04-03 08:17:42 -0500 | Rating Details | |
| 2024-04-03 08:05:35 -0500 | Rating Details | |
| 2024-04-03 07:22:29 -0500 | Rating Details | |
| 2024-04-03 07:15:23 -0500 | Rating Details | |
| 2024-04-03 07:12:30 -0500 | Rating Details | |
| 2024-04-03 07:09:44 -0500 | Rating Details | |
| 2024-04-03 07:08:09 -0500 | Rating Details | |
| 2024-04-03 07:01:00 -0500 | Rating Details | |
| 2024-04-03 06:51:46 -0500 | Rating Details | |
| 2024-04-03 06:51:13 -0500 | Rating Details | |
| 2024-04-03 06:34:22 -0500 | Rating Details | |
| 2024-04-03 06:02:37 -0500 | Rating Details | |
| 2024-04-03 05:37:00 -0500 | Rating Details | |
| 2024-04-03 12:54:08 -0500 | Rating Details | |
| 2024-04-03 12:24:15 -0500 | Rating Details | |
| 2024-04-03 12:14:40 -0500 | Rating Details | |
| 2024-04-03 11:54:20 -0500 | Rating Details | |
| 2024-04-03 11:47:40 -0500 | Rating Details | |
| 2024-04-03 11:46:36 -0500 | Rating Details | |
| 2024-04-03 11:34:23 -0500 | Rating Details | |
| 2024-04-03 11:33:43 -0500 | Rating Details | |
| 2024-04-03 11:19:17 -0500 | Rating Details | |
| 2024-04-03 10:58:28 -0500 | Rating Details | |
| 2024-04-03 10:47:48 -0500 | Rating Details | |
| 2024-04-03 10:09:15 -0500 | Rating Details | |
| 2024-04-03 09:53:13 -0500 | Rating Details | |
| 2024-04-03 09:38:04 -0500 | Rating Details | |
| 2024-04-03 09:36:42 -0500 | Rating Details | |
| 2024-04-03 09:12:05 -0500 | Rating Details | |
| 2024-04-03 09:02:11 -0500 | Rating Details | |
| 2024-04-03 08:51:53 -0500 | Rating Details | |
| 2024-04-03 08:32:51 -0500 | Rating Details | |
| 2024-04-03 07:58:26 -0500 | Rating Details | |
| 2024-04-03 07:47:01 -0500 | Rating Details | |
| 2024-04-03 07:45:10 -0500 | Rating Details | |
| 2024-04-03 07:43:38 -0500 | Rating Details | |
| 2024-04-03 07:17:33 -0500 | Rating Details | |
| 2024-04-03 07:16:02 -0500 | Rating Details | |
| 2024-04-03 07:15:05 -0500 | Rating Details | |
| 2024-04-03 07:10:07 -0500 | Rating Details | |
| 2024-04-03 07:00:53 -0500 | Rating Details | |
| 2024-04-03 06:57:15 -0500 | Rating Details | |
| 2024-04-03 06:49:32 -0500 | Rating Details | |
| 2024-04-03 06:38:53 -0500 | Rating Details | |
| 2024-04-03 06:32:48 -0500 | Rating Details | |
| 2024-04-03 06:32:28 -0500 | Rating Details | |
| 2024-04-03 06:29:00 -0500 | Rating Details | |
| 2024-04-03 06:05:36 -0500 | Rating Details | |
| 2024-04-03 05:56:11 -0500 | Rating Details | |
| 2024-04-03 05:47:57 -0500 | Rating Details | |
| 2024-04-03 05:41:20 -0500 | Rating Details | |
| 2024-04-03 05:14:58 -0500 | Rating Details | |
| 2024-04-03 05:06:44 -0500 | Rating Details | |
| 2024-04-03 05:04:52 -0500 | Rating Details | |
| 2024-04-03 04:57:04 -0500 | Rating Details | |
| 2024-04-03 04:55:35 -0500 | Rating Details | |
| 2024-04-03 04:50:18 -0500 | Rating Details | |
| 2024-04-03 04:46:10 -0500 | Rating Details | |
| 2024-04-03 04:42:00 -0500 | Rating Details | |
| 2024-04-03 04:33:11 -0500 | Rating Details | |
| 2024-04-03 04:27:51 -0500 | Rating Details | |
| 2024-04-03 04:14:38 -0500 | Rating Details | |
| 2024-04-03 04:10:52 -0500 | Rating Details | |
| 2024-04-03 04:04:42 -0500 | Rating Details | |
| 2024-04-03 04:04:42 -0500 | Rating Details | |
| 2024-04-03 04:00:50 -0500 | Rating Details | |
| 2024-04-03 03:58:30 -0500 | Rating Details | |
| 2024-04-03 03:55:36 -0500 | Rating Details | |
| 2024-04-03 03:52:39 -0500 | Rating Details | |
| 2024-04-03 03:49:06 -0500 | Rating Details | |
| 2024-04-03 03:43:42 -0500 | Rating Details | |
| 2024-04-03 03:41:11 -0500 | Rating Details | |
| 2024-04-03 03:40:04 -0500 | Rating Details | |
| 2024-04-03 03:28:49 -0500 | Rating Details | |
| 2024-04-03 07:08:39 -0500 | Rating Details |